This inventor holds 4 USPTO granted patents. Top assignee: The Dow Chemical Company. Active years: 1979-1981.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1979-1981
Title: The Innovations of Roger D McDermott
Introduction
Roger D McDermott is a notable inventor based in Noblesville, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes and hyperglycemia. With a total of 4 patents to his name, McDermott's work has the potential to impact many lives.
Latest Patents
Among his latest patents are "Hypoglycemic phenylpropynylamino benzoic acids" and "Method for treating hyperglycemia in mammals using arylamino benzoic." The first patent focuses on hypoglycemic compositions that are useful for lowering serum sugars and treating diabetes. The second patent outlines a method for treating hyperglycemia in mammals by administering a hypoglycemic amount of an arylamino benzoic acid or its pharmaceutically-acceptable salt.
Career Highlights
Roger D McDermott is currently associated with The Dow Chemical Company, where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a commitment to improving health outcomes for individuals suffering from diabetes and related conditions.
Collaborations
Some of his notable coworkers include Eugene R Wagner and Donald Paul Matthews, who have likely contributed to his research and development efforts.
Conclusion
Roger D McDermott's contributions to the field of pharmaceuticals demonstrate his dedication to innovation and improving health. His patents reflect a deep understanding of the complexities of diabetes treatment, and his work continues to pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile